Clinical Trial Update: A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safe and effective use of the prefilled syringe or auto-injector for subcutaneous self-injection of bimekizumab in adults with mode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2023-08-08